NRGene expands with a New Office & Genotyping Lab in Canada
NRGene (TASE: NRGN), a leading genomics company, announces the official opening of its new office and genotyping lab in Saskatoon, Canada. The opening event will...
Tag : genome technology
Genomics leader Sequential Skin raise $1.65M in oversubscription
Sequential Skin Ltd, a UK/Singapore biotech start-up has raised US $1.65M in its oversubscribed seed round – to revolutionise the future of skin health. The round was led...
Genomics leader NuProbe enables Mutation Detection on Nanopore
NuProbe scientists and collaborators recently published a new method for sensitive detection of somatic mutations using Oxford Nanopore sequencing platforms. The method, termed oncogene concatenated...
RNA Oncology Company TransCode Therapeutics Awarded Funding
TTX-MC138 targets MicroRNA10b for treatment of metastatic disease; TransCode on track to submit exploratory investigational new drug (eIND) application in Q1 2022 TransCode Therapeutics, Inc....
Genomic Medicine Co. Sangamo Therapeutics Reports Q2 Results
Conference Call and Webcast Scheduled for 4:30 p.m. Eastern Time Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported recent business highlights and...
Non-invasive Skin Genomics Platform DermTech Reports Q2 2021 Results
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported unaudited financial results for the quarter...
Personal Genome Diagnostics Welcomes Maggie Rougier-Chapman
Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the appointment of Maggie Rougier-Chapman as Senior Vice President, Head of Marketing and...
Genomic Diagnostics Co. Veracyte Announces Q2 Financial Results
Total Revenue Increased 166% to $55.1 million; Genomic Volume Grew 215% to 20,856 Tests Company Advanced Clinical Evidence, Pipeline and Global Growth Strategy Raises 2021...
Genomic Vision: First-half 2021 Results
H1 2021 sales impacted by the Covid-19 crisis (-24.6% to €467 thousand) Encouraging upturn in activity in Q2, with sales almost doubling vs. Q1 6.2%...
Deep Genomics Raises $180M in Series C Financing
Company expands AI discovery platform for ‘Programmable’ RNA therapeutics and supports advancement of its portfolio into the clinic Oversubscribed round led by SoftBank Vision Fund...